A case of ustekinumab-induced sclerouveitis.
Citation: American Journal of Ophthalmology Case Reports. 25:101331, 2022 Mar.PMID: 35146201Institution: MedStar Washington Hospital CenterDepartment: Ophthalmology ResidencyForm of publication: Journal ArticleMedline article type(s): Case ReportsSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2022Abstract: Conclusions: To the best of our knowledge, this is the first reported case of this type seen with ustekinumab injections. Our goal is to add to the existing literature in order to better understand the mechanism and management of this condition. Copyright (c) 2022 The Authors.Observations: In this report, we present a case of a suspected ustekinumab-associated recurrent sclerouveitis.Purpose: Biologics have proven to be essential therapeutic agents in immune-mediated systemic diseases. Ophthalmologic adverse effects have been reported in the use of more traditional agents, such as TNF-alpha inhibitors, but there are limited data on ocular side effects associated with the newer generation of biologics.Fiscal year: FY2022Digital Object Identifier: Date added to catalog: 2022-02-22| Item type | Current library | Collection | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Journal Article | MedStar Authors Catalog | Article | 35146201 | Available | 35146201 |
Conclusions: To the best of our knowledge, this is the first reported case of this type seen with ustekinumab injections. Our goal is to add to the existing literature in order to better understand the mechanism and management of this condition. Copyright (c) 2022 The Authors.
Observations: In this report, we present a case of a suspected ustekinumab-associated recurrent sclerouveitis.
Purpose: Biologics have proven to be essential therapeutic agents in immune-mediated systemic diseases. Ophthalmologic adverse effects have been reported in the use of more traditional agents, such as TNF-alpha inhibitors, but there are limited data on ocular side effects associated with the newer generation of biologics.
English